Position in PCRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,015,621
+$163,445 QoQ
Shares Held
44,939
+36.5% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Gotham Asset Management, LLC holds $204,070,964 across 22 Drug Manufacturers - Specialty & Generic names. PCRX ranks #11 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
4,500,352 | $60,799,755 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
80,387 | $47,667,883 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
360,136 | $47,444,316 | |
| 4 | ZTS |
Zoetis Inc.
|
212,586 | $25,129,791 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
331,032 | $7,921,595 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
312,961 | $2,979,388 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
24,095 | $1,852,905 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
55,614 | $1,839,154 |
All Filings in PCRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,015,621 | 44,939 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $852,176 | 32,928 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $858,991 | 33,333 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,007,671 | 42,162 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,072,799 | 43,171 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,223,620 | 64,948 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,368,240 | 90,913 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $827,630 | 28,928 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $395,668 | 13,541 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $733,102 | 21,728 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $684,685 | 22,317 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $765,897 | 19,114 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,242,623 | 30,449 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $270,152 | 5,079 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $232,150 | 3,982 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $496,690 | 6,508 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,478,617 | 24,574 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,141,056 | 20,376 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $460,075 | 7,582 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $510,325 | 7,281 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $718,498 | 12,007 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $713,624 | 11,870 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $713,696 | 13,602 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,019,813 | 60,239 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||